1272 related articles for article (PubMed ID: 12377813)
61. Intraductal papillary mucinous tumor of the pancreas (IPMT): follow-up of twelve cases.
Khalid A; Funch-Jensen P; Bendix J; Dutoit Hamilton S; Kruse A; Viborg Mortensen F
Scand J Surg; 2009; 98(1):25-9. PubMed ID: 19447738
[TBL] [Abstract][Full Text] [Related]
62. Minute invasive ductal carcinoma of the residual pancreas after distal pancreatectomy for intraductal papillary-mucinous tumor.
Moriya T; Kimura W; Sakurai F; Semba S; Ozawa K; Hirai I; Fuse A
Int J Gastrointest Cancer; 2002; 31(1-3):191-7. PubMed ID: 12622431
[TBL] [Abstract][Full Text] [Related]
63. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
64. Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity.
Andrejevic-Blant S; Kosmahl M; Sipos B; Klöppel G
Virchows Arch; 2007 Nov; 451(5):863-9. PubMed ID: 17899180
[TBL] [Abstract][Full Text] [Related]
65. Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection.
Gaitanidis A; Alevizakos M; Tsaroucha A; Tsalikidis C; Simopoulos C; Pitiakoudis M
Eur J Surg Oncol; 2018 May; 44(5):693-699. PubMed ID: 29426780
[TBL] [Abstract][Full Text] [Related]
66. Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications.
Baiocchi GL; Portolani N; Missale G; Baronchelli C; Gheza F; Cantù M; Grazioli L; Giulini SM
World J Surg Oncol; 2010 Apr; 8():25. PubMed ID: 20374620
[TBL] [Abstract][Full Text] [Related]
67. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
Raut CP; Cleary KR; Staerkel GA; Abbruzzese JL; Wolff RA; Lee JH; Vauthey JN; Lee JE; Pisters PW; Evans DB
Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362
[TBL] [Abstract][Full Text] [Related]
68. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.
Hwang DW; Jang JY; Lee SE; Lim CS; Lee KU; Kim SW
Langenbecks Arch Surg; 2012 Jan; 397(1):93-102. PubMed ID: 20640860
[TBL] [Abstract][Full Text] [Related]
69. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
70. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
[TBL] [Abstract][Full Text] [Related]
71. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
72. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
[TBL] [Abstract][Full Text] [Related]
73. Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.
Partelli S; Fernandez-Del Castillo C; Bassi C; Mantovani W; Thayer SP; Crippa S; Ferrone CR; Falconi M; Pederzoli P; Warshaw AL; Salvia R
Ann Surg; 2010 Mar; 251(3):477-82. PubMed ID: 20142730
[TBL] [Abstract][Full Text] [Related]
74. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
[TBL] [Abstract][Full Text] [Related]
75. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.
Salvia R; Fernández-del Castillo C; Bassi C; Thayer SP; Falconi M; Mantovani W; Pederzoli P; Warshaw AL
Ann Surg; 2004 May; 239(5):678-85; discussion 685-7. PubMed ID: 15082972
[TBL] [Abstract][Full Text] [Related]
76. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity.
Rivera JA; Fernández-del Castillo C; Pins M; Compton CC; Lewandrowski KB; Rattner DW; Warshaw AL
Ann Surg; 1997 Jun; 225(6):637-44; discussion 644-6. PubMed ID: 9230804
[TBL] [Abstract][Full Text] [Related]
77. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
[TBL] [Abstract][Full Text] [Related]
78. Clinicopathologic features and outcomes of intraductal papillary-mucinous tumors of the pancreas.
Sugiura H; Kondo S; Islam HK; Ito K; Ono K; Morikawa T; Okushiba S; Katoh H
Hepatogastroenterology; 2002; 49(43):263-7. PubMed ID: 11941971
[TBL] [Abstract][Full Text] [Related]
79. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
[TBL] [Abstract][Full Text] [Related]
80. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.
Passot G; Lebeau R; Hervieu V; Ponchon T; Pilleul F; Adham M
Pancreas; 2012 Jan; 41(1):137-41. PubMed ID: 22076564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
